← Open Payments lookup

JESSICA ADAMS: Open Payments

NPI 1841484060 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,738 in 85 payments from 17 companies in 2025. Trend: 2023 $4,180 · 2024 $2,285 · 2025 $1,738

Food & beverage: $1,738
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$349
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$286
ABBVIE INC.19$257
E.R. Squibb & Sons, L.L.C.10$238
Supernus Pharmaceuticals, Inc.6$160
Axsome Therapeutics, Inc.4$75
Vanda Pharmaceuticals Inc.3$69
Alkermes, Inc.3$61
Corium, LLC3$53
Janssen Pharmaceuticals, Inc3$46

Products named: INGREZZA, CAPLYTA, VRAYLAR, COBENFY, Qelbree, FANAPT, ARISTADA, REXULTI.

Industry payments across VA — which companies pay providers there.